16.900
+9,74%
2026-10-08
Fundamental Analysis
44 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +1.8% | +10.5% | 3 / 3 | +3.6% | +4.42 pp | -0.04 pp | +14.1% | 0.00 | 5.69 | 66,5 | +3,6% | 1,6 | +1,8% | 5.69 | 5.93 | −4,1% |
| Pts | 0 | 0 | 12 | 0 | 12 | 4 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 16.900 (close price on 2026-10-08)EPS (TTM): 2.972
Financial charts
1.Revenue & growth
VND bn66,4Q2/26
1.Revenue & growth
VND bn66,4Q2/26
2.Profit & growth
VND bn1,62Q2/26
3.Profit mix (Penman)
VND bn14,9Q2/26
4.Margins & cost structure
%39.6%Q2/26
5.Returns & cash cycle
% · days37.4%Q2/26
6.Earnings quality & cash
VND bn5,17Q2/26
7.Asset structure
VND bn173Q2/26
8.Funding & debt health
VND bn · times173Q2/26
9.Revenue backlog
VND bn0,14Q2/26
10.Valuation
times · %5,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %407Q2/26
Adjusted EPS growth, latest quarter
2.9%
Average adjusted EPS growth, 3 quarters
10.9%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26